During the past decade, Yale Univ School of Medicine / AIDS Program conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Yale Univ School of Medicine / AIDS Program" #1 sponsor was "Gilead Sciences" with 5 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 3 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored, "Merck Sharp & Dohme LLC" with 1 trials sponsored and "The New York Academy of Medicine" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Yale Univ School of Medicine / AIDS Program" #1 collaborator was "Boehringer Ingelheim" with 1 trials as a collaborator, "Brown University" with 1 trials as a collaborator, "CORE Center, Cook County Bureau of Health Services" with 1 trials as a collaborator, "El Rio Santa Cruz Neighborhood Health Center" with 1 trials as a collaborator and "Health Resources and Services Administration (HRSA)" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Yale Univ School of Medicine / AIDS Program" are "HIV Infections" (11 trials), "HIV" (3 trials), "AIDS" (1 trials), "Acquired Immunodeficiency Syndrome" (1 trials) and "HIV-1 Infection" (1 trials). Many other conditions were trialed in "Yale Univ School of Medicine / AIDS Program" in a lesser frequency.

Most popular intervention types in "Yale Univ School of Medicine / AIDS Program" are "Drug" (12 trials), "Behavioral" (2 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "ATV" (3 trials), "COBI" (2 trials), "E/C/F/TDF" (2 trials), "FTC/TDF" (2 trials) and "Indinavir sulfate" (2 trials). Other intervention names were less common.

The vast majority of trials in "Yale Univ School of Medicine / AIDS Program" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Yale Univ School of Medicine / AIDS Program". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Yale Univ School of Medicine / AIDS Program, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Yale Univ School of Medicine / AIDS Program, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".